209 related articles for article (PubMed ID: 24570215)
1. Determinants of newly diagnosed comorbidities among breast cancer survivors.
Obi N; Gornyk D; Heinz J; Vrieling A; Seibold P; Chang-Claude J; Flesch-Janys D
J Cancer Surviv; 2014 Sep; 8(3):384-93. PubMed ID: 24570215
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of lifestyle factors and bone health in breast cancer patients who received aromatase inhibitors in an integrated healthcare setting.
Kwan ML; Lo JC; Laurent CA; Roh JM; Tang L; Ambrosone CB; Kushi LH; Quesenberry CP; Yao S
J Cancer Surviv; 2023 Feb; 17(1):139-149. PubMed ID: 33565036
[TBL] [Abstract][Full Text] [Related]
3. Hormone therapy and osteoporosis in breast cancer survivors: assessment of risk and adherence to screening recommendations.
Hamood R; Hamood H; Merhasin I; Keinan-Boker L
Osteoporos Int; 2019 Jan; 30(1):187-200. PubMed ID: 30413856
[TBL] [Abstract][Full Text] [Related]
4. Adiposity, post-diagnosis weight change, and risk of cardiovascular events among early-stage breast cancer survivors.
Cespedes Feliciano EM; Kwan ML; Kushi LH; Weltzien EK; Castillo AL; Caan BJ
Breast Cancer Res Treat; 2017 Apr; 162(3):549-557. PubMed ID: 28176174
[TBL] [Abstract][Full Text] [Related]
5. Comorbidities and cardiovascular disease risk in older breast cancer survivors.
Haque R; Prout M; Geiger AM; Kamineni A; Thwin SS; Avila C; Silliman RA; Quinn V; Yood MU
Am J Manag Care; 2014; 20(1):86-92. PubMed ID: 24512167
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular Disease After Aromatase Inhibitor Use.
Haque R; Shi J; Schottinger JE; Chung J; Avila C; Amundsen B; Xu X; Barac A; Chlebowski RT
JAMA Oncol; 2016 Dec; 2(12):1590-1597. PubMed ID: 27100398
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for self-reported arm lymphedema among female breast cancer survivors: a prospective cohort study.
Togawa K; Ma H; Sullivan-Halley J; Neuhouser ML; Imayama I; Baumgartner KB; Smith AW; Alfano CM; McTiernan A; Ballard-Barbash R; Bernstein L
Breast Cancer Res; 2014 Aug; 16(4):414. PubMed ID: 25145603
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutically treated anxiety but not depression prior to cancer diagnosis predicts the onset of cardiovascular disease among breast cancer survivors.
Schoormans D; van de Poll-Franse L; Vissers P; van Herk-Sukel MPP; Pedersen SS; Rottmann N; Horsbøl T; Dalton S; Denollet J
Breast Cancer Res Treat; 2017 Nov; 166(1):259-266. PubMed ID: 28717854
[TBL] [Abstract][Full Text] [Related]
9. Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer.
Rillamas-Sun E; Kwan ML; Iribarren C; Cheng R; Neugebauer R; Rana JS; Nguyen-Huynh M; Shi Z; Laurent CA; Lee VS; Roh JM; Huang Y; Shen H; Hershman DL; Kushi LH; Greenlee H
Breast Cancer Res Treat; 2023 Aug; 201(1):117-126. PubMed ID: 37326764
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular disease risk in long-term breast cancer survivors: A population-based cohort study.
Koric A; Chang CP; Mark B; Rowe K; Snyder J; Dodson M; Deshmukh VG; Newman MG; Fraser AM; Smith KR; Date AP; Gren LH; Porucznik CA; Haaland BA; Henry NL; Hashibe M
Cancer; 2022 Jul; 128(14):2826-2835. PubMed ID: 35561317
[TBL] [Abstract][Full Text] [Related]
11. All-Cause and Cardiovascular Disease Mortality Among Breast Cancer Survivors in CLUE II, a Long-Standing Community-Based Cohort.
Ramin C; Schaeffer ML; Zheng Z; Connor AE; Hoffman-Bolton J; Lau B; Visvanathan K
J Natl Cancer Inst; 2021 Feb; 113(2):137-145. PubMed ID: 32634223
[TBL] [Abstract][Full Text] [Related]
12. Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study.
Hamood R; Hamood H; Merhasin I; Keinan-Boker L
J Cardiol; 2019 Apr; 73(4):280-291. PubMed ID: 30587455
[TBL] [Abstract][Full Text] [Related]
13. Trastuzumab-related cardiotoxicity among older patients with breast cancer.
Chavez-MacGregor M; Zhang N; Buchholz TA; Zhang Y; Niu J; Elting L; Smith BD; Hortobagyi GN; Giordano SH
J Clin Oncol; 2013 Nov; 31(33):4222-8. PubMed ID: 24127446
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of osteopenia and osteoporosis in younger breast cancer survivors compared with cancer-free women: a prospective cohort study.
Ramin C; May BJ; Roden RBS; Orellana MM; Hogan BC; McCullough MS; Petry D; Armstrong DK; Visvanathan K
Breast Cancer Res; 2018 Nov; 20(1):134. PubMed ID: 30424783
[TBL] [Abstract][Full Text] [Related]
15. Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study.
Bowles EJ; Wellman R; Feigelson HS; Onitilo AA; Freedman AN; Delate T; Allen LA; Nekhlyudov L; Goddard KA; Davis RL; Habel LA; Yood MU; McCarty C; Magid DJ; Wagner EH;
J Natl Cancer Inst; 2012 Sep; 104(17):1293-305. PubMed ID: 22949432
[TBL] [Abstract][Full Text] [Related]
16. Use of antidepressants and NSAIDs in relation to mortality in long-term breast cancer survivors.
Wernli KJ; Hampton JM; Trentham-Dietz A; Newcomb PA
Pharmacoepidemiol Drug Saf; 2011 Feb; 20(2):131-7. PubMed ID: 21254283
[TBL] [Abstract][Full Text] [Related]
17. Body mass index and mortality among older breast cancer survivors in the Study of Osteoporotic Fractures.
Reeves KW; Faulkner K; Modugno F; Hillier TA; Bauer DC; Ensrud KE; Cauley JA;
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1468-73. PubMed ID: 17627012
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular Disease Mortality Among Breast Cancer Survivors.
Bradshaw PT; Stevens J; Khankari N; Teitelbaum SL; Neugut AI; Gammon MD
Epidemiology; 2016 Jan; 27(1):6-13. PubMed ID: 26414938
[TBL] [Abstract][Full Text] [Related]
19. Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK.
Bromley SE; Matthews A; Smeeth L; Stanway S; Bhaskaran K
J Cancer Surviv; 2019 Aug; 13(4):632-640. PubMed ID: 31321612
[TBL] [Abstract][Full Text] [Related]
20. Risk of cardiovascular adverse events from trastuzumab (Herceptin(®)) in elderly persons with breast cancer: a population-based study.
Tsai HT; Isaacs C; Fu AZ; Warren JL; Freedman AN; Barac A; Huang CY; Potosky AL
Breast Cancer Res Treat; 2014 Feb; 144(1):163-70. PubMed ID: 24469642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
